Dialysis world news


Artificial Kidney Promises Freedom - Renal Business Today

NEW YORK—The Wearable Artificial Kidney (WAK) will offer patients across the world suffering from kidney failure freedom from endless hospital appointments— and hospitals the chance to save on resources—states a new report by medical industry experts GBI Research.

The new report shows the growing prevalence of diabetes and hypertension, alongside an increasingly large elderly population, has meant that doctors have encountered a rapid growth in the number of patients suffering from End Stage Renal Disease (ESRD), which has put pressure on burgeoning healthcare budgets. However, the lucrative market these patients represent for dialysis device manufacturers has led to the development of the WAK, the latest innovation to provide patient care on a global scale.

One in 10 adults are at risk of chronic kidney disease (CKD), totaling roughly 500 million people worldwide, and the rising diabetic population is increasing the prevalence of diabetic nephropathy, which is a leading cause of CKD and ESRD. Serious kidney damage demands medical attention, and the WAK is the latest treatment option, offering continuous dialysis treatment to patients with ESRD by using nanomaterials such as carbon nanotubes to imitate normal kidney function.

Individuals gain a dramatically improved quality of life, as treatment requires minimal patient intervention. WAKs are fully automated, battery operated, lightweight, waterproof, do not restrict lifestyle or diet, and eliminate normal dialysis procedures, which can take up to four hours, three times a week. WAKs also avoid the sudden electrolyte imbalances associated with timed dialysis, and recycle bodily fluids to reduce protein loss and eliminate water loss, providing ESRD patients with safer care.

...

 
Global Surgical Devices Market Growth Driven by Improving Standards of Living ... - DigitalJournal.com (press release)

FARMINGTON, Conn., April 17, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce three significant new reports showing strong growth in the medical devices markets, driven by improving standards of living and longer life expectancies:

Renal Dialysis Equipment Market to 2017
The growing prevalence of diabetes, hypertension and an increasingly large elderly population are driving rapid growth in the number of End Stage Renal Disease (ESRD) patients the market globally, according to GBI Research's new report, "Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis". Factors such as the improving standards of living in developing economies and longer life expectancies of dialysis patients, due to improved access to healthcare services are also expected to boost the market.

This report provides key data, information and analysis on the global renal dialysis equipment market, covering the market landscape, competitive landscape and market trends relating to four renal dialysis equipment market categories: dialysis accessories, continuous renal replacement therapy machines, peritoneal dialysis solutions and hemodialysis machines. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category, providing comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. This research also reviews the details of important merger and acquisition deals that have taken place in the renal dialysis equipment market, and is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/gbi235837-renal-dialysis-equipment-market-2017-lower-costs.html

Artificial Organs Market Forecast
As the market for Artificial Organs heats up, Global Industry Analysts, Inc's new Artificial Organs market forecast and research report analyzes the worldwide markets for Artificial Organs in US $ Million. This 289 page report pulls together detailed analysis for multiple market segments, including Artificial Hearts, Artificial Kidneys, Artificial Livers, Artificial Pancreases, and Artificial Lungs. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

This report is an excellent resource for businesses, governments, researchers, and private executives who are actively involved in the Artificial Organs market, including healthcare groups, organ developers, research institutions, and regulatory bodies. This report offers a full Artificial Organs industry overview; examines market trends and issues; offers a summary of competitive scenarios including competition in the artificial pancreas domain, the competitive landscape of the artificial kidneys, dialyzers, and ventricular assist devices markets; a full product overview of dozens of artificial organs, their strengths and weaknesses and potential areas of opportunity; an analysis of global and local regulatory environments, and more.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/go236739-artificial-organs.html

Prefilled Syringes to 2016: Devices, Therapeutics, Players, Markets and Prospects
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Greystone Research Associates' new Prefilled Syringes market research offers a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prefilled syringes and injectable devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/grey235995-prefilled-syringes-2016-devices-therapeutics.html

About Global Information Inc.Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, This e-mail address is being protected from spambots. You need JavaScript enabled to view it

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.

...

 
Health minister launches awareness campaign on Cisco Care-at-a-Distance ... - Petra News Agency

...

 
Global Surgical Devices Market Growth Driven by Improving Standards of Living ... - PR Newswire (press release)
<![CDATA[ .translangcomp{ float:left; clear:left; margin-top:15px; *margin-top:-2px; margin-left:90px } ]]> <![CDATA[ .news-print1{background:url(http://content.prnewswire.com/designimages/print_PRN.jpg) no-repeat 2px 8px; display: block; font-size:12px; font-weight:100; height:10px; padding:11px 5px 11px 30px; } ]]><![CDATA[ .cf_arrowtail{ visibility:hidden; } ]]>

FARMINGTON, Conn., April 17, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce three significant new reports showing strong growth in the medical devices markets, driven by improving standards of living and longer life expectancies:

Renal Dialysis Equipment Market to 2017
The growing prevalence of diabetes, hypertension and an increasingly large elderly population are driving rapid growth in the number of End Stage Renal Disease (ESRD) patients the market globally, according to GBI Research's new report, "Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis". Factors such as the improving standards of living in developing economies and longer life expectancies of dialysis patients, due to improved access to healthcare services are also expected to boost the market.

This report provides key data, information and analysis on the global renal dialysis equipment market, covering the market landscape, competitive landscape and market trends relating to four renal dialysis equipment market categories: dialysis accessories, continuous renal replacement therapy machines, peritoneal dialysis solutions and hemodialysis machines. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category, providing comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. This research also reviews the details of important merger and acquisition deals that have taken place in the renal dialysis equipment market, and is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/gbi235837-renal-dialysis-equipment-market-2017-lower-costs.html

Artificial Organs Market Forecast
As the market for Artificial Organs heats up, Global Industry Analysts, Inc's new Artificial Organs market forecast and research report analyzes the worldwide markets for Artificial Organs in US $ Million. This 289 page report pulls together detailed analysis for multiple market segments, including Artificial Hearts, Artificial Kidneys, Artificial Livers, Artificial Pancreases, and Artificial Lungs. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

This report is an excellent resource for businesses, governments, researchers, and private executives who are actively involved in the Artificial Organs market, including healthcare groups, organ developers, research institutions, and regulatory bodies. This report offers a full Artificial Organs industry overview; examines market trends and issues; offers a summary of competitive scenarios including competition in the artificial pancreas domain, the competitive landscape of the artificial kidneys, dialyzers, and ventricular assist devices markets; a full product overview of dozens of artificial organs, their strengths and weaknesses and potential areas of opportunity; an analysis of global and local regulatory environments, and more.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/go236739-artificial-organs.html

Prefilled Syringes to 2016: Devices, Therapeutics, Players, Markets and Prospects
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Greystone Research Associates' new Prefilled Syringes market research offers a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prefilled syringes and injectable devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/grey235995-prefilled-syringes-2016-devices-therapeutics.html

About Global Information Inc.Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, This e-mail address is being protected from spambots. You need JavaScript enabled to view it

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.

Back to top

RELATED LINKS
http://www.giiresearch.com

...

 
A common cholesterol medication may impact kidney health - Medical Xpress
Medical Xpress
After a number of similar experiences in their renal clinics, Dr. Garg and his colleagues felt these events merited further examination. In a large, "real practice" study, the team examined more than 20000 older Ontario residents with new prescriptions

...

 
<< Start < Prev 441 442 443 444 445 446 447 448 449 450 Next > End >>

Page 447 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.